I'm beginning to worry that RVX might be being priced out of starting the trial. Clinical centers often agree to participate in clinical trials on a per patient funding basis. So they get paid a negotiated amount (agreed in advance) for each patient recruited and completed. As BP can afford to pay more per patient, RVX might have to wait a long time!